Industry Developments

BMI View: Litha Healthcare Group's strategy of rapid acquisitions to diversify its product sales in vaccines, pharmaceuticals and medical devices is well timed to take advantage of... 2011-12-14

BMI View: Diabetes is the Middle East and North Africa (MENA)'s biggest epidemiological challenge. The rapid societal transition to a more urbanised lifestyle with little exercise and... 2011-12-13

BMI View: Kuwait's healthcare system is undergoing a period of transition from a primarily state-run public healthcare system to an increased number of public-private partnerships (PPPs),... 2011-12-12

BMI View: With Muammar al-Qadhafi dead and Libya now on an uncertain but possibly stable path to democracy, BMI believes the drugmakers that make the most effort to engage with the... 2011-12-01

BMI View: Post-apartheid South Africa has underinvested in research and development (R&D), which has had a knock-on effect on the country's ability to compete in the field of clinical... 2011-12-01

BMI View: With Muammar al-Qadhafi dead and Libya now on an uncertain but possibly stable path to democracy, BMI believes the drugmakers that make the most effort to engage with the... 2011-11-30

BMI View: While Israel has historically been a cheap and effective site for clinical trials, it is becoming increasingly expensive compared to emerging markets and it also cannot compete... 2011-11-29

BMI View: The African Public Health Emergency Fund (APHEF) is a tangible demonstration of Africa's growing confidence and self-reliance. If introduced, it will help to counter the erosion... 2011-11-28

BMI View: The countries of the Gulf Cooperation Council (GCC) have plenty of opportunities for newly established drug manufacturers. The political will from governments seeking to diversify... 2011-11-25

BMI View: We like Julphar's regional strategy, especially its diversified product portfolio with sales across the Middle East and North Africa (MENA). Their joint venture with Cigalah... 2011-11-24